東和薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/06/29 | 1,815 | 1,824 | 1,796 | 1,800 | -21 | -1.2% | 107,400 |
2023/06/28 | 1,802 | 1,821 | 1,800 | 1,821 | +19 | +1.1% | 105,800 |
2023/06/27 | 1,821 | 1,826 | 1,792 | 1,802 | -27 | -1.5% | 91,400 |
2023/06/26 | 1,823 | 1,835 | 1,808 | 1,829 | +6 | +0.3% | 84,900 |
2023/06/23 | 1,832 | 1,837 | 1,812 | 1,823 | +2 | +0.1% | 122,300 |
2023/06/22 | 1,815 | 1,827 | 1,813 | 1,821 | +11 | +0.6% | 177,900 |
2023/06/21 | 1,806 | 1,820 | 1,805 | 1,810 | +1 | +0.1% | 77,200 |
2023/06/20 | 1,810 | 1,813 | 1,795 | 1,809 | +2 | +0.1% | 107,100 |
2023/06/19 | 1,792 | 1,827 | 1,792 | 1,807 | +26 | +1.5% | 153,800 |
2023/06/16 | 1,763 | 1,786 | 1,757 | 1,781 | +18 | +1% | 176,300 |
2023/06/15 | 1,776 | 1,776 | 1,760 | 1,763 | -15 | -0.8% | 135,200 |
2023/06/14 | 1,788 | 1,792 | 1,775 | 1,778 | -8 | -0.4% | 114,000 |
2023/06/13 | 1,804 | 1,813 | 1,784 | 1,786 | -14 | -0.8% | 101,300 |
2023/06/12 | 1,800 | 1,808 | 1,797 | 1,800 | +3 | +0.2% | 74,900 |
2023/06/09 | 1,788 | 1,804 | 1,784 | 1,797 | +12 | +0.7% | 103,600 |
2023/06/08 | 1,797 | 1,797 | 1,774 | 1,785 | +7 | +0.4% | 74,800 |
2023/06/07 | 1,786 | 1,817 | 1,778 | 1,778 | -2 | -0.1% | 173,500 |
2023/06/06 | 1,764 | 1,780 | 1,747 | 1,780 | +9 | +0.5% | 127,700 |
2023/06/05 | 1,801 | 1,801 | 1,767 | 1,771 | +7 | +0.4% | 143,100 |
2023/06/02 | 1,733 | 1,764 | 1,728 | 1,764 | +40 | +2.3% | 99,200 |
2023/06/01 | 1,751 | 1,774 | 1,723 | 1,724 | -31 | -1.8% | 203,700 |
2023/05/31 | 1,803 | 1,806 | 1,754 | 1,755 | -62 | -3.4% | 206,300 |
2023/05/30 | 1,853 | 1,856 | 1,813 | 1,817 | -29 | -1.6% | 135,500 |
2023/05/29 | 1,850 | 1,860 | 1,840 | 1,846 | -10 | -0.5% | 106,800 |
2023/05/26 | 1,870 | 1,870 | 1,849 | 1,856 | -6 | -0.3% | 106,100 |
2023/05/25 | 1,891 | 1,891 | 1,861 | 1,862 | -31 | -1.6% | 106,000 |
2023/05/24 | 1,914 | 1,914 | 1,892 | 1,893 | -13 | -0.7% | 69,200 |
2023/05/23 | 1,929 | 1,933 | 1,898 | 1,906 | -9 | -0.5% | 84,500 |
2023/05/22 | 1,903 | 1,919 | 1,896 | 1,915 | ±0 | ±0% | 120,800 |
2023/05/19 | 1,939 | 1,939 | 1,906 | 1,915 | -19 | -1% | 77,100 |
2023/05/18 | 1,954 | 1,954 | 1,933 | 1,934 | -2 | -0.1% | 85,000 |
2023/05/17 | 1,990 | 1,993 | 1,935 | 1,936 | -48 | -2.4% | 108,100 |
2023/05/16 | 1,940 | 1,993 | 1,938 | 1,984 | +79 | +4.1% | 207,100 |
2023/05/15 | 1,915 | 1,919 | 1,899 | 1,905 | +7 | +0.4% | 84,600 |
2023/05/12 | 1,906 | 1,915 | 1,885 | 1,898 | -18 | -0.9% | 101,200 |
2023/05/11 | 1,929 | 1,933 | 1,908 | 1,916 | -25 | -1.3% | 73,600 |
2023/05/10 | 1,968 | 1,968 | 1,935 | 1,941 | -24 | -1.2% | 48,300 |
2023/05/09 | 1,950 | 1,966 | 1,947 | 1,965 | +22 | +1.1% | 54,400 |
2023/05/08 | 1,943 | 1,954 | 1,936 | 1,943 | -1 | -0.1% | 62,000 |
2023/05/02 | 1,968 | 1,969 | 1,933 | 1,944 | -24 | -1.2% | 57,000 |
2023/05/01 | 1,959 | 1,971 | 1,956 | 1,968 | +32 | +1.7% | 68,200 |
2023/04/28 | 1,930 | 1,952 | 1,928 | 1,936 | +32 | +1.7% | 96,500 |
2023/04/27 | 1,895 | 1,911 | 1,887 | 1,904 | ±0 | ±0% | 62,800 |
2023/04/26 | 1,922 | 1,922 | 1,897 | 1,904 | -25 | -1.3% | 50,500 |
2023/04/25 | 1,923 | 1,937 | 1,919 | 1,929 | +25 | +1.3% | 58,500 |
2023/04/24 | 1,916 | 1,922 | 1,904 | 1,904 | -9 | -0.5% | 70,700 |
2023/04/21 | 1,918 | 1,923 | 1,903 | 1,913 | +3 | +0.2% | 36,500 |
2023/04/20 | 1,911 | 1,915 | 1,900 | 1,910 | -4 | -0.2% | 49,300 |
2023/04/19 | 1,935 | 1,935 | 1,912 | 1,914 | -30 | -1.5% | 44,200 |
2023/04/18 | 1,939 | 1,945 | 1,934 | 1,944 | +12 | +0.6% | 59,300 |
451~
500
件表示中 / 6945件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
東和薬品 | 263,700円 | +15.0% | -7.3% | 2.65% | 8.65倍 | 0.82倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
サンバイオ | 229,900円 | - | - | 0.00% | - | 106.48倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
鳥居薬 | 523,000円 | +7.1% | -35.0% | 2.29% | 43.25倍 | 1.21倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
ゼリア新薬 | 234,300円 | +14.2% | +41.0% | 1.96% | 11.48倍 | 1.17倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 241,500円 | +21.7% | +999.9% | 0.00% | 10.06倍 | 3.33倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム